AcuCort AB Sustainability Reports
AcuCort AB is an innovative biotech company that develops and commercializes bio-dissolvable oral films. Its primary product is Zeqmelit, a fast-dissolving oral film containing dexamethasone used to treat severe allergic reactions and acute asthma.
Sector: Professional & technical services
Country: Sweden
Exchange: Nordic Growth Market
LEI: 54930087FR3VVW5SU676
FIGI: BBG00GD2ZMG1
2 reports from 2021 to 2022
